3,048 results match your criteria: "Karolinska University Hospital Huddinge.[Affiliation]"

Relapse after complete remission (CR) remains the main cause of mortality after allogeneic stem cell transplantation for hematological malignancies and, therefore, improved biomarkers for early prediction of relapse remains a critical goal toward development and assessment of preemptive relapse treatment. Because the significance of cancer stem cells as a source of relapses remains unclear, we investigated whether mutational screening for persistence of rare cancer stem cells would enhance measurable residual disease (MRD) and early relapse prediction after transplantation. In a retrospective study of patients who relapsed and patients who achieved continuous-CR with myelodysplastic syndromes and related myeloid malignancies, combined flow cytometric cell sorting and mutational screening for persistence of rare relapse-initiating stem cells was performed in the bone marrow at multiple CR time points after transplantation.

View Article and Find Full Text PDF

XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma.

Expert Opin Ther Targets

January 2024

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.

Introduction: Despite improvements in clinical management of hepatocellular carcinoma (HCC), prognosis remains poor with a 5-year survival rate less than 40%. Drug resistance in HCC makes it challenging to treat; therefore, it is imperative to develop new therapeutic strategies. Higher expression of X-box binding protein 1 (XBP1) in tumor cells is highly correlated with poor prognosis.

View Article and Find Full Text PDF

The role of compression in large scale data transfer and storage of typical biomedical signals at hospitals.

Health Informatics J

December 2023

Department of Biomedical Engineering and Health Systems, KTH Royal Institute of Technology, Huddinge, Sweden; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden; Department of Clinical Physiology, Karolinska University Hospital Huddinge, Sweden.

In modern hospitals, monitoring patients' vital signs and other biomedical signals is standard practice. With the advent of data-driven healthcare, Internet of medical things, wearable technologies, and machine learning, we expect this to accelerate and to be used in new and promising ways, including early warning systems and precision diagnostics. Hence, we see an ever-increasing need for retrieving, storing, and managing the large amount of biomedical signal data generated.

View Article and Find Full Text PDF

Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.

J Allergy Clin Immunol Pract

March 2024

Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Solna, Division of Clinical Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska University Hospital, Stockholm, Sweden. Electronic address:

Background: Idiopathic mast cell activation syndrome (iMCAS) is characterized by severe, episodic systemic mast cell (MC) activation and mediator-related symptoms, an event-related increase in serum tryptase levels, and response to MC-targeted therapies in the absence of underlying IgE-mediated allergy or clonal MC disorder. Studies indicating its prevalence using evidence-based diagnostic criteria are lacking.

Objective: To assess the prevalence and clinical and laboratory features of patients with iMCAS.

View Article and Find Full Text PDF

Clinical and immunological features in ACKR1/DARC-associated neutropenia.

Blood Adv

February 2024

Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.

ACKR1/DARC-associated neutropenia (NP; ADAN; Online Mendelian Inheritance in Man 611862), caused by a variation in the ACKR1/DARC gene (rs2814778), is common in persons of African or Middle Eastern descent. In a cohort of 66 genetically confirmed subjects with ADAN, we show that absolute neutrophil counts (ANCs) may occasionally be lower than previously recognized (0.1 × 109-0.

View Article and Find Full Text PDF

Objective: Standardised person-reported outcomes (PRO) data can contextualise clinical outcomes enabling precision diabetes monitoring and care. Comprehensive outcome sets can guide this process, but their implementation in routine diabetes care has remained challenging and unsuccessful at international level. We aimed to address this by developing a person-centred outcome set for Type 1 and Type 2 diabetes, using a methodology with prospects for increased implementability and sustainability in international health settings.

View Article and Find Full Text PDF
Article Synopsis
  • Congenital adrenal hyperplasia (CAH) is caused by 21α-hydroxylase deficiency, leading to low cortisol and aldosterone levels while increasing adrenal androgens, with treatment challenges in growth and obesity.
  • A study involved 86 Swedish CAH patients to analyze how growth, final height (FH), and body mass index (BMI) relate to different CYP21A2 genotypes and glucocorticoid treatment approaches over time.
  • Results showed that patients with severe genotypes had shorter FH, and those treated with prednisolone had higher BMI at age 18, but overall glucocorticoid dose did not correlate with height outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers synthesized a targeting agent, N-stearyl lactobionamide (N-SALB), and created solid lipid nanoparticles (SLNs) loaded with BTZ (Gal-SLNs/BTZ) that effectively target HCC cells, showing positive results in particle size and drug loading efficiency.
  • * In vitro and in vivo studies indicated that N-SALB-targeted nanoparticles had significantly higher uptake and cytotoxic effects in HCC cells compared to non-targeted versions, leading to improved
View Article and Find Full Text PDF

Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation.

Gastroenterology

April 2024

Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address:

Background & Aims: Chronic inflammation surrounding bile ducts contributes to the disease pathogenesis of most cholangiopathies. Poor efficacy of immunosuppression in these conditions suggests biliary-specific pathologic principles. Here we performed biliary niche specific functional interpretation of a causal mutation (CD100 K849T) of primary sclerosing cholangitis (PSC) to understand related pathogenic mechanisms.

View Article and Find Full Text PDF

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.

Diagnostics (Basel)

October 2023

Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.

Our knowledge of biology and mast cell (MC) function, as well as disorders associated with the pathologic activation of MCs, has evolved over the last few decades. Anaphylaxis, mast cell activation syndrome (MCAS), and mastocytosis are interrelated yet distinct conditions within the spectrum of mast cell activation disorders. Nevertheless, all three conditions can co-exist in one and the same patient, as pathologic MC activation is the key finding in all three.

View Article and Find Full Text PDF

Extending the cystatin C based EKFC-equation to children - validation results from Europe.

Pediatr Nephrol

April 2024

Department of Nephrology-Dialysis-Transplantation, University of Liège (ULg CHU), CHU Sart Tilman, Liège, Belgium.

Background: A new cystatin C based European Kidney Function Consortium (EKFC) equation was recently developed for adults, using the same mathematical form as the previously published full age spectrum creatinine based EKFC-equation (EKFC). In the present study the cystatin C based EKFC-equation is extended to children, by defining the appropriate cystatin C rescaling factor Q.

Methods: Rescaling factor Q for cystatin C was defined as: a) 0.

View Article and Find Full Text PDF

Background: Collagens are the major components of the extracellular matrix (ECM) and are known to contribute to tumor progression and metastasis. There are 28 different types of collagens each with unique functions in maintaining tissue structure and function. Type XVII collagen (BP180) is a type II transmembrane protein that provides stable adhesion between epithelial cells and the underlying basement membrane.

View Article and Find Full Text PDF

A meta-analysis conducted by Harris and Orth (2020) found positive prospective cross-lagged effects between quality of social relations and self-esteem in included longitudinal studies. Harris and Orth concluded that the link between self-esteem and quality of social relations is reciprocal and characterized by a positive feedback loop. However, meta-analytic effects were estimated while controlling for a prior measurement of the outcome and such effects are known to be susceptible to artifactual (i.

View Article and Find Full Text PDF

Preventive chemotherapy with single-dose praziquantel is the WHO-recommended intervention strategy to eliminate schistosomiasis as a public health problem in endemic countries. Surveillance of drugs used in mass drug administration (MDA) programs is recommended to evaluate its effectiveness in reducing transmissions. After a decade-long implementation of a school-based MDA program in Rwanda, we conducted efficacy surveillance of single-dose praziquantel MDA against infection.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess the prevalence of atherosclerosis in coronary and carotid arteries among individuals with prediabetes and diabetes compared to those without diabetes, involving over 30,000 participants aged 50-64.
  • - The findings revealed that participants with prediabetes or diabetes had significantly higher levels of coronary artery plaque, stenosis, and calcium scores compared to normoglycaemic individuals, indicating a greater cardiovascular risk.
  • - Notably, the prevalence of coronary atherosclerosis was highest in those with known diabetes, while both prediabetic and diabetic participants showed increased plaque in carotid arteries compared to normoglycaemic individuals.
View Article and Find Full Text PDF

Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.

Immunol Allergy Clin North Am

November 2023

Department of Respiratory Medicine and Allergy, K85, Karolinska University Hospital Huddinge, Stockholm, SE-14186, Sweden; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Centre Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address:

Mastocytosis is characterized by expansion and activation of clonally aberrant mast cells (MCs) in one or more organ systems. Inappropriate MC activation is a key finding in both allergy and mastocytosis; therefore, symptoms in both conditions show some degree of overlap. When mediator release is excessive and involves multiple systems, anaphylaxis may occur.

View Article and Find Full Text PDF

The African Liver Tissue Biorepository Consortium: Capacitating Population-Appropriate Drug Metabolism, Pharmacokinetics, and Pharmacogenetics Research in Drug Discovery and Development.

Drug Metab Dispos

December 2023

African institute of biomedical Science and Technology (AiBST), Harare, Zimbabwe (C.M., C.R.K., N.N.K., R.S.T.); Sydney Brenner Institute of Molecular Bioscience (SBIMB), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (C.M., M.R., B.M., N.S.); Wits Donald Gordon Medical Centre (WDGMC), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (H.E., H.M., S.R., B.S., F.V.S., J.L., J.F.); Karolinska Institute, Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Transplantation Surgery, Karolinska University Hospital Huddinge, Sweden (E.E.); Bioengineering and Integrated Genomics Group, Next Generation Health Cluster, Council for Scientific and Industrial Research (CSIR), Pretoria, South Africa (T.H., J.N., J.S.); and Transplant Services, Intermountain Medical Center, Salt Lake City, Utah (J.B.).

Pharmaceutical companies subject all new molecular entities to a series of in vitro metabolic characterizations that guide the selection and/or design of compounds predicted to have favorable pharmacokinetic properties in humans. Current drug metabolism research is based on liver tissue predominantly obtained from people of European origin, with limited access to tissue from people of African origin. Given the interindividual and interpopulation genomic variability in genes encoding drug-metabolizing enzymes, efficacy and safety of some drugs are poorly predicted for African populations.

View Article and Find Full Text PDF

Background: A growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS), but it has not yet been integrated into most national clinical guidelines. The objective of this study was to assess efficacy and safety when aHSCT is implemented in routine healthcare.

Methods: We assessed 231 patients and the final analysis included 174 RRMS patients who were treated with aHSCT in Sweden before 1 January 2020.

View Article and Find Full Text PDF

A survey of preferences for respiratory support in the intensive care unit for patients with acute hypoxaemic respiratory failure.

Acta Anaesthesiol Scand

November 2023

Department of Anaesthesiology and Intensive Care Medicine, Division of Emergencies and Critical Care, Rikshopitalet, Oslo University Hospital, Oslo, Norway.

Background: When caring for mechanically ventilated adults with acute hypoxaemic respiratory failure (AHRF), clinicians are faced with an uncertain choice between ventilator modes allowing for spontaneous breaths or ventilation fully controlled by the ventilator. The preferences of clinicians managing such patients, and what motivates their choice of ventilator mode, are largely unknown. To better understand how clinicians' preferences may impact the choice of ventilatory support for patients with AHRF, we issued a survey to an international network of intensive care unit (ICU) researchers.

View Article and Find Full Text PDF

Obesity is a major risk factor for the development of nonalcoholic fatty liver disease (NAFLD), and the subcutaneous white adipose tissue (scWAT) is the primary lipid storage depot and regulates lipid fluxes to other organs. Our previous work identified genes upregulated in scWAT of patients with NAFLD: , , and . Herein, we knocked down (KD) their expression in human adipose-derived mesenchymal stem cells (hADMSCs) using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology and characterized their phenotype.

View Article and Find Full Text PDF

Background: Autoimmunity can be the first or predominant manifestation in patients with primary immunodeficiency disorder, also known as inborn errors of immunity (IEI). This study aims to evaluate the immune status of pediatric patients with polyautoimmunity to identify those with underlying immune defects.

Methods: In this cross-sectional study, pediatric patients with polyautoimmunity including at least one confirmed autoimmune endocrine disease were enrolled.

View Article and Find Full Text PDF

Mucins 3A and 3B Are Expressed in the Epithelium of Human Large Airway.

Int J Mol Sci

August 2023

Respiratory Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.

Aberrant mucus secretion is a hallmark of chronic obstructive pulmonary disease (COPD). Expression of the membrane-tethered mucins 3A and 3B (MUC3A, MUC3B) in human lung is largely unknown. In this observational cross-sectional study, we recruited subjects 45-65 years old from the general population of Stockholm, Sweden, during the years 2007-2011.

View Article and Find Full Text PDF

The COVID-19 pandemic has had a significant impact on medical practices, including the delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant centers have made changes to their procedures, including an increased use of cryopreservation for allogeneic haematopoietic progenitor cell (HPC) grafts. The use of cryopreserved grafts for allogeneic HCT has been reviewed and analysed in terms of potential benefits and drawbacks based on existing data on impact on cell subsets, hematological recovery, and clinical outcomes of approximately 2000 patients from different studies.

View Article and Find Full Text PDF